This result appears of particular relevance when considering the central role of the chemokine in the pathogenesis of ARDS [56], since it suggests that alternative therapeutic strategies have to be developed to target the neutrophil–IL-8 axis in severe COVID-19. This evidence concerns the gene CXCL8 and acute respiratory distress syndrome.